Wnt signaling and tumors (Review) Huaishi Wang et al, 2024, Molecular and Clinical Oncology CrossRef
Tankyrases as modulators of pro-tumoral functions: molecular insights and therapeutic opportunities Esteban Zamudio-Martinez et al, 2021, Journal of Experimental & Clinical Cancer Research CrossRef
The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro Dmitry Stakheev et al, 2019, Scientific Reports CrossRef
Small-Molecule Inhibitors of Tankyrases as Prospective Therapeutics for Cancer Mingfeng Yu et al, 2022, Journal of Medicinal Chemistry CrossRef
Wnt/β-catenin Signaling in Lung Cancer: Association with Proliferation, Metastasis, and Therapy Resistance Maliheh Entezari et al, 2024, Current Cancer Drug Targets CrossRef
Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer Haixiang Yu et al, 2019, Canadian Respiratory Journal CrossRef
The multidimensional role of the Wnt/β‐catenin signaling pathway in human malignancies Ishita S. Hiremath et al, 2022, Journal of Cellular Physiology CrossRef
WNT/β-Catenin Signaling Pathway Regulating T Cell-Inflammation in the Tumor Microenvironment Xin Li et al, 2019, Frontiers in Immunology CrossRef
GOLPH3 Promotes Angiogenesis of Lung Adenocarcinoma by Regulating the Wnt/β-Catenin Signaling Pathway
Canjun Zhao et al, 2020, OncoTargets and Therapy CrossRef
Bioactivity Studies of Hesperidin and XAV939 Ahmed E. Fazary et al, 2021, ACS Omega CrossRef
Ocular Wnt/β-Catenin Pathway Inhibitor XAV939-Loaded Liposomes for Treating Alkali-Burned Corneal Wound and Neovascularization Yueyang Zhong et al, 2021, Frontiers in Bioengineering and Biotechnology CrossRef
Inhibition of beta-catenin shows therapeutic potential in head and neck squamous cell carcinoma in vitro Tobias Maier et al, 2023, European Archives of Oto-Rhino-Laryngology CrossRef